Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function
Chunlin Zhuang, Zhongli Wu, Chengguo Xing, et al.
MedChemComm (2016) Vol. 8, Iss. 2, pp. 286-294
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Vy Ngo, Martin L. Duennwald
Antioxidants (2022) Vol. 11, Iss. 12, pp. 2345-2345
Open Access | Times Cited: 398
Nrf2/Keap1/ARE signaling: Towards specific regulation
A. V. Ulasov, Andrey A. Rosenkranz, Georgii P. Georgiev, et al.
Life Sciences (2021) Vol. 291, pp. 120111-120111
Open Access | Times Cited: 329
Interfering peptides targeting protein–protein interactions: the next generation of drugs?
Heriberto Bruzzoni‐Giovanelli, Valérie Alezra, Nicolas Wolff, et al.
Drug Discovery Today (2017) Vol. 23, Iss. 2, pp. 272-285
Closed Access | Times Cited: 130
A potent phosphodiester Keap1-Nrf2 protein-protein interaction inhibitor as the efficient treatment of Alzheimer's disease
Yi Sun, Lijuan Xu, Dongpeng Zheng, et al.
Redox Biology (2023) Vol. 64, pp. 102793-102793
Open Access | Times Cited: 24
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
Clara Mayer, Lluís Riera‐Ponsati, Sakari Kauppinen, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 10
Discovery of β-amino acid substituted naphthalene sulfonamide derivatives as potent Kelch-like ECH-associated protein 1−nuclear factor erythroid 2-related factor 2 (Keap1−Nrf2) protein−protein interaction inhibitors for ulcerative colitis management
Ziquan Zhao, Hongjin Lu, Junjie Wang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117384-117384
Closed Access | Times Cited: 1
Navigating the Complexities of Neuronal Signaling and Targets in Neurological Disorders: From Pathology to Therapeutics
Divya Choudhary, Muhammad Imran Khan, Zuber Khan, et al.
European Journal of Pharmacology (2025), pp. 177417-177417
Closed Access | Times Cited: 1
Discovery of a head-to-tail cyclic peptide as the Keap1-Nrf2 protein-protein interaction inhibitor with high cell potency
Mengchen Lu, Qiong Jiao, Tian Liu, et al.
European Journal of Medicinal Chemistry (2017) Vol. 143, pp. 1578-1589
Closed Access | Times Cited: 70
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
Yi Mou, Shuai Wen, Yuxiu Li, et al.
European Journal of Medicinal Chemistry (2020) Vol. 202, pp. 112532-112532
Closed Access | Times Cited: 69
Theoretical Study of the Antioxidant Activity of Quercetin Oxidation Products
Alejandro Vásquez‐Espinal, Osvaldo Yáñez, Edison Osorio, et al.
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 67
Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications
Mahdie Rahban, Mehran Habibi-Rezaei, Mansooreh Mazaheri, et al.
Antioxidants (2020) Vol. 9, Iss. 12, pp. 1228-1228
Open Access | Times Cited: 64
Role of antioxidants and a nutrient rich diet in Alzheimer's disease
Gerald Veurink, George Perry, Sandeep Kumar Singh
Open Biology (2020) Vol. 10, Iss. 6
Open Access | Times Cited: 55
Direct inhibition of Keap1-Nrf2 Protein-Protein interaction as a potential therapeutic strategy for Alzheimer's disease
Yi Sun, Jiaxuan Huang, Yufei Chen, et al.
Bioorganic Chemistry (2020) Vol. 103, pp. 104172-104172
Open Access | Times Cited: 51
Nrf2, the Major Regulator of the Cellular Oxidative Stress Response, is Partially Disordered
Nadun C. Karunatilleke, Courtney S. Fast, Vy Ngo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7434-7434
Open Access | Times Cited: 42
Gamma-oryzanol alleviates osteoarthritis development by targeting Keap1–Nrf2 binding to interfere with chondrocyte ferroptosis
Zi-Han Dai, Chen-Cheng Zhou, Caiyu Yu, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111469-111469
Closed Access | Times Cited: 8
NRF2-mediated regulation of lipid pathways in viral infection
Khursheed Muzammil, Zahraa Sabah Ghnim, Ibrahim Saeed Gataa, et al.
Molecular Aspects of Medicine (2024) Vol. 97, pp. 101279-101279
Closed Access | Times Cited: 7
Identification of a novel small-molecule Keap1–Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy
Cheng‐Shi Jiang, Chunlin Zhuang, Kongkai Zhu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 833-841
Open Access | Times Cited: 53
Leonurine ameliorates D-galactose-induced aging in mice through activation of the Nrf2 signalling pathway
Peng Chen, Fuchao Chen, Benhong Zhou
Aging (2019) Vol. 11, Iss. 18, pp. 7339-7356
Open Access | Times Cited: 51
Emerging Substrate Proteins of Kelch-like ECH Associated Protein 1 (Keap1) and Potential Challenges for the Development of Small-Molecule Inhibitors of the Keap1-Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Protein–Protein Interaction
Yong Zhang, Zeyu Shi, Yujun Zhou, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 15, pp. 7986-8002
Closed Access | Times Cited: 50
Emerging Screening Approaches in the Development of Nrf2–Keap1 Protein–Protein Interaction Inhibitors
Chung‐Hang Leung, Jia-Tong Zhang, Guan‐Jun Yang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4445-4445
Open Access | Times Cited: 47
A bioactive ligand-conjugated iridium(III) metal-based complex as a Keap1–Nrf2 protein-protein interaction inhibitor against acetaminophen-induced acute liver injury
Guodong Li, Hao Liu, Ruibing Feng, et al.
Redox Biology (2021) Vol. 48, pp. 102129-102129
Open Access | Times Cited: 36
Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance
Supriya Bevinakoppamath, Shobha Chikkavaddaragudi Ramachandra, Anshu Yadav, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 24
Natural Product-Inspired Targeted Protein Degraders: Advances and Perspectives
Jiao Li, Zhenyu Cai, Xu‐Wen Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 13533-13560
Closed Access | Times Cited: 23
Design, Synthesis, and Structure–Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein–Protein Interaction Inhibitors
Hai-Shan Zhou, Lv-Bin Hu, Han Zhang, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 19, pp. 11149-11168
Closed Access | Times Cited: 39
A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions
Mengchen Lu, Xian Zhang, Jing Zhao, et al.
Redox Biology (2020) Vol. 34, pp. 101565-101565
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top